Effect of Scopolamine Butylbromide on Clozapine-induced Hypersalivation in Schizophrenic Patients: A Case Series

Clozapine has been demonstrated to be useful for treating refractory schizophrenia. However, hypersalivation occurs in 31.0–97.4% of the patients treated with clozapine. Accordingly, some patients who are disturbed by their hypersalivation refuse to continue with clozapine treatment. This study inve...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeuchi, Ippei, Suzuki, Tatsuyo, Kishi, Taro, Kanamori, Daisuke, Hanya, Manako, Uno, Junji, Fujita, Kiyoshi, Kamei, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Neuropsychopharmacology 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423163/
https://www.ncbi.nlm.nih.gov/pubmed/25912544
http://dx.doi.org/10.9758/cpn.2015.13.1.109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423163/
https://www.ncbi.nlm.nih.gov/pubmed/25912544
http://dx.doi.org/10.9758/cpn.2015.13.1.109

Ejemplares similares